THPO and Thrombocytopenia: Since the production of endogenous thrombopoietin is constant regardless of platelet count, stimulating megakaryocyte growth, differentiation, and platelet production may be a potential solution to overcome the severe thrombocytopenia induced by ADC, rather than interruption or suspension of treatment (22, 23).